nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—HTR6—Alzheimer's disease	0.194	0.514	CbGaD
Ziprasidone—HTR3A—Memantine—Alzheimer's disease	0.123	0.387	CbGbCtD
Ziprasidone—SLC6A4—Alzheimer's disease	0.0744	0.197	CbGaD
Ziprasidone—HTR2A—Donepezil—Alzheimer's disease	0.0576	0.182	CbGbCtD
Ziprasidone—HTR2A—Alzheimer's disease	0.0572	0.151	CbGaD
Ziprasidone—CYP2D6—Alzheimer's disease	0.0523	0.138	CbGaD
Ziprasidone—DRD2—Memantine—Alzheimer's disease	0.046	0.145	CbGbCtD
Ziprasidone—CYP2D6—Rivastigmine—Alzheimer's disease	0.024	0.0755	CbGbCtD
Ziprasidone—CYP2D6—Donepezil—Alzheimer's disease	0.0192	0.0604	CbGbCtD
Ziprasidone—CYP3A4—Rivastigmine—Alzheimer's disease	0.0152	0.048	CbGbCtD
Ziprasidone—CYP2D6—Galantamine—Alzheimer's disease	0.0123	0.0389	CbGbCtD
Ziprasidone—CYP3A4—Donepezil—Alzheimer's disease	0.0122	0.0384	CbGbCtD
Ziprasidone—CYP3A4—Galantamine—Alzheimer's disease	0.00785	0.0247	CbGbCtD
Ziprasidone—HTR2C—choroid plexus—Alzheimer's disease	0.00494	0.0771	CbGeAlD
Ziprasidone—DRD3—telencephalic ventricle—Alzheimer's disease	0.0026	0.0406	CbGeAlD
Ziprasidone—HTR2A—choroid plexus—Alzheimer's disease	0.00248	0.0387	CbGeAlD
Ziprasidone—HTR7—locus ceruleus—Alzheimer's disease	0.00245	0.0383	CbGeAlD
Ziprasidone—DRD1—telencephalic ventricle—Alzheimer's disease	0.00186	0.0291	CbGeAlD
Ziprasidone—HTR2A—locus ceruleus—Alzheimer's disease	0.00153	0.0239	CbGeAlD
Ziprasidone—HTR1B—telencephalic ventricle—Alzheimer's disease	0.00151	0.0236	CbGeAlD
Ziprasidone—HTR1D—telencephalic ventricle—Alzheimer's disease	0.00146	0.0228	CbGeAlD
Ziprasidone—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00145	0.0226	CbGeAlD
Ziprasidone—HTR2A—cerebellar cortex—Alzheimer's disease	0.00125	0.0195	CbGeAlD
Ziprasidone—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00122	0.019	CbGeAlD
Ziprasidone—HTR7—telencephalic ventricle—Alzheimer's disease	0.00116	0.0182	CbGeAlD
Ziprasidone—DRD2—telencephalic ventricle—Alzheimer's disease	0.0011	0.0172	CbGeAlD
Ziprasidone—HTR1E—forebrain—Alzheimer's disease	0.000833	0.013	CbGeAlD
Ziprasidone—HTR1E—telencephalon—Alzheimer's disease	0.000766	0.012	CbGeAlD
Ziprasidone—HTR1B—blood vessel—Alzheimer's disease	0.000747	0.0117	CbGeAlD
Ziprasidone—HTR2A—telencephalic ventricle—Alzheimer's disease	0.000726	0.0113	CbGeAlD
Ziprasidone—HTR1D—blood vessel—Alzheimer's disease	0.000723	0.0113	CbGeAlD
Ziprasidone—Lurasidone—HTR2A—Alzheimer's disease	0.000676	0.249	CrCbGaD
Ziprasidone—HTR6—forebrain—Alzheimer's disease	0.000654	0.0102	CbGeAlD
Ziprasidone—DRD5—forebrain—Alzheimer's disease	0.000637	0.00994	CbGeAlD
Ziprasidone—HTR6—telencephalon—Alzheimer's disease	0.000601	0.00938	CbGeAlD
Ziprasidone—DRD5—telencephalon—Alzheimer's disease	0.000585	0.00914	CbGeAlD
Ziprasidone—HTR7—blood vessel—Alzheimer's disease	0.000576	0.00899	CbGeAlD
Ziprasidone—H1F0—embryo—Alzheimer's disease	0.000557	0.00869	CbGeAlD
Ziprasidone—Aripiprazole—HTR6—Alzheimer's disease	0.000548	0.202	CrCbGaD
Ziprasidone—H1F0—forebrain—Alzheimer's disease	0.000493	0.00769	CbGeAlD
Ziprasidone—DRD1—forebrain—Alzheimer's disease	0.000486	0.00759	CbGeAlD
Ziprasidone—HTR3A—forebrain—Alzheimer's disease	0.00047	0.00733	CbGeAlD
Ziprasidone—H1F0—telencephalon—Alzheimer's disease	0.000453	0.00707	CbGeAlD
Ziprasidone—HTR1E—nervous system—Alzheimer's disease	0.000452	0.00706	CbGeAlD
Ziprasidone—DRD1—telencephalon—Alzheimer's disease	0.000447	0.00698	CbGeAlD
Ziprasidone—HTR1E—central nervous system—Alzheimer's disease	0.000436	0.0068	CbGeAlD
Ziprasidone—HTR3A—telencephalon—Alzheimer's disease	0.000432	0.00674	CbGeAlD
Ziprasidone—DRD4—brain—Alzheimer's disease	0.000401	0.00626	CbGeAlD
Ziprasidone—CHRM4—nervous system—Alzheimer's disease	0.000397	0.00619	CbGeAlD
Ziprasidone—HTR1B—forebrain—Alzheimer's disease	0.000394	0.00615	CbGeAlD
Ziprasidone—CHRM2—forebrain—Alzheimer's disease	0.000392	0.00612	CbGeAlD
Ziprasidone—CHRM4—central nervous system—Alzheimer's disease	0.000382	0.00596	CbGeAlD
Ziprasidone—HTR1D—forebrain—Alzheimer's disease	0.000382	0.00596	CbGeAlD
Ziprasidone—HTR2C—forebrain—Alzheimer's disease	0.000378	0.0059	CbGeAlD
Ziprasidone—DRD3—nervous system—Alzheimer's disease	0.000369	0.00576	CbGeAlD
Ziprasidone—HTR1B—telencephalon—Alzheimer's disease	0.000362	0.00566	CbGeAlD
Ziprasidone—CHRM2—telencephalon—Alzheimer's disease	0.000361	0.00563	CbGeAlD
Ziprasidone—HTR2A—blood vessel—Alzheimer's disease	0.000359	0.00561	CbGeAlD
Ziprasidone—SLC6A4—forebrain—Alzheimer's disease	0.000358	0.00559	CbGeAlD
Ziprasidone—CHRM1—forebrain—Alzheimer's disease	0.000357	0.00557	CbGeAlD
Ziprasidone—DRD3—central nervous system—Alzheimer's disease	0.000355	0.00554	CbGeAlD
Ziprasidone—HTR6—nervous system—Alzheimer's disease	0.000355	0.00554	CbGeAlD
Ziprasidone—HTR1D—telencephalon—Alzheimer's disease	0.000351	0.00548	CbGeAlD
Ziprasidone—HTR2C—telencephalon—Alzheimer's disease	0.000347	0.00542	CbGeAlD
Ziprasidone—HTR1E—brain—Alzheimer's disease	0.000346	0.0054	CbGeAlD
Ziprasidone—DRD5—nervous system—Alzheimer's disease	0.000346	0.00539	CbGeAlD
Ziprasidone—HTR6—central nervous system—Alzheimer's disease	0.000342	0.00533	CbGeAlD
Ziprasidone—DRD5—central nervous system—Alzheimer's disease	0.000333	0.00519	CbGeAlD
Ziprasidone—SLC6A4—telencephalon—Alzheimer's disease	0.000329	0.00514	CbGeAlD
Ziprasidone—CHRM1—telencephalon—Alzheimer's disease	0.000328	0.00512	CbGeAlD
Ziprasidone—CHRM3—forebrain—Alzheimer's disease	0.000319	0.00498	CbGeAlD
Ziprasidone—HTR1A—forebrain—Alzheimer's disease	0.000318	0.00496	CbGeAlD
Ziprasidone—CHRM5—nervous system—Alzheimer's disease	0.00031	0.00484	CbGeAlD
Ziprasidone—HTR7—forebrain—Alzheimer's disease	0.000304	0.00474	CbGeAlD
Ziprasidone—CHRM4—brain—Alzheimer's disease	0.000303	0.00473	CbGeAlD
Ziprasidone—CHRM5—central nervous system—Alzheimer's disease	0.000299	0.00466	CbGeAlD
Ziprasidone—Clozapine—HTR6—Alzheimer's disease	0.000294	0.108	CrCbGaD
Ziprasidone—CHRM3—telencephalon—Alzheimer's disease	0.000294	0.00458	CbGeAlD
Ziprasidone—ADRA1A—forebrain—Alzheimer's disease	0.000293	0.00458	CbGeAlD
Ziprasidone—HTR1A—telencephalon—Alzheimer's disease	0.000292	0.00456	CbGeAlD
Ziprasidone—DRD2—forebrain—Alzheimer's disease	0.000287	0.00449	CbGeAlD
Ziprasidone—ADRA1B—nervous system—Alzheimer's disease	0.000283	0.00442	CbGeAlD
Ziprasidone—KCNH2—forebrain—Alzheimer's disease	0.000283	0.00442	CbGeAlD
Ziprasidone—DRD3—brain—Alzheimer's disease	0.000282	0.0044	CbGeAlD
Ziprasidone—HTR7—telencephalon—Alzheimer's disease	0.00028	0.00436	CbGeAlD
Ziprasidone—ADRA1B—central nervous system—Alzheimer's disease	0.000273	0.00426	CbGeAlD
Ziprasidone—HTR6—brain—Alzheimer's disease	0.000271	0.00423	CbGeAlD
Ziprasidone—ADRA1A—telencephalon—Alzheimer's disease	0.00027	0.00421	CbGeAlD
Ziprasidone—H1F0—nervous system—Alzheimer's disease	0.000267	0.00417	CbGeAlD
Ziprasidone—DRD2—telencephalon—Alzheimer's disease	0.000264	0.00412	CbGeAlD
Ziprasidone—DRD5—brain—Alzheimer's disease	0.000264	0.00412	CbGeAlD
Ziprasidone—DRD1—nervous system—Alzheimer's disease	0.000264	0.00412	CbGeAlD
Ziprasidone—KCNH2—telencephalon—Alzheimer's disease	0.00026	0.00406	CbGeAlD
Ziprasidone—H1F0—central nervous system—Alzheimer's disease	0.000257	0.00402	CbGeAlD
Ziprasidone—ADRA2C—telencephalon—Alzheimer's disease	0.000257	0.00401	CbGeAlD
Ziprasidone—HTR3A—nervous system—Alzheimer's disease	0.000255	0.00398	CbGeAlD
Ziprasidone—DRD1—central nervous system—Alzheimer's disease	0.000254	0.00397	CbGeAlD
Ziprasidone—H1F0—cerebellum—Alzheimer's disease	0.000252	0.00393	CbGeAlD
Ziprasidone—HTR3A—central nervous system—Alzheimer's disease	0.000246	0.00383	CbGeAlD
Ziprasidone—CHRM5—brain—Alzheimer's disease	0.000237	0.0037	CbGeAlD
Ziprasidone—HRH1—forebrain—Alzheimer's disease	0.000227	0.00354	CbGeAlD
Ziprasidone—ADRA2A—forebrain—Alzheimer's disease	0.000223	0.00348	CbGeAlD
Ziprasidone—ADRA1B—brain—Alzheimer's disease	0.000217	0.00338	CbGeAlD
Ziprasidone—HTR2A—embryo—Alzheimer's disease	0.000214	0.00334	CbGeAlD
Ziprasidone—HTR1B—nervous system—Alzheimer's disease	0.000214	0.00334	CbGeAlD
Ziprasidone—CHRM2—nervous system—Alzheimer's disease	0.000213	0.00332	CbGeAlD
Ziprasidone—Aripiprazole—SLC6A4—Alzheimer's disease	0.00021	0.0772	CrCbGaD
Ziprasidone—HRH1—telencephalon—Alzheimer's disease	0.000209	0.00326	CbGeAlD
Ziprasidone—Trazodone—SLC6A4—Alzheimer's disease	0.000209	0.0768	CrCbGaD
Ziprasidone—HTR1D—nervous system—Alzheimer's disease	0.000207	0.00323	CbGeAlD
Ziprasidone—HTR1B—central nervous system—Alzheimer's disease	0.000206	0.00321	CbGeAlD
Ziprasidone—HTR2C—nervous system—Alzheimer's disease	0.000205	0.0032	CbGeAlD
Ziprasidone—ADRA2A—telencephalon—Alzheimer's disease	0.000205	0.0032	CbGeAlD
Ziprasidone—CHRM2—central nervous system—Alzheimer's disease	0.000205	0.0032	CbGeAlD
Ziprasidone—H1F0—brain—Alzheimer's disease	0.000204	0.00319	CbGeAlD
Ziprasidone—DRD1—brain—Alzheimer's disease	0.000202	0.00315	CbGeAlD
Ziprasidone—HTR1D—central nervous system—Alzheimer's disease	0.000199	0.00311	CbGeAlD
Ziprasidone—HTR2C—central nervous system—Alzheimer's disease	0.000198	0.00308	CbGeAlD
Ziprasidone—HTR3A—brain—Alzheimer's disease	0.000195	0.00304	CbGeAlD
Ziprasidone—SLC6A4—nervous system—Alzheimer's disease	0.000194	0.00303	CbGeAlD
Ziprasidone—CHRM1—nervous system—Alzheimer's disease	0.000194	0.00302	CbGeAlD
Ziprasidone—HTR2A—forebrain—Alzheimer's disease	0.00019	0.00296	CbGeAlD
Ziprasidone—SLC6A4—central nervous system—Alzheimer's disease	0.000187	0.00292	CbGeAlD
Ziprasidone—CHRM1—central nervous system—Alzheimer's disease	0.000187	0.00291	CbGeAlD
Ziprasidone—HTR2A—telencephalon—Alzheimer's disease	0.000174	0.00272	CbGeAlD
Ziprasidone—CHRM3—nervous system—Alzheimer's disease	0.000173	0.00271	CbGeAlD
Ziprasidone—CYP2D6—forebrain—Alzheimer's disease	0.000173	0.0027	CbGeAlD
Ziprasidone—HTR1A—nervous system—Alzheimer's disease	0.000173	0.00269	CbGeAlD
Ziprasidone—CHRM3—central nervous system—Alzheimer's disease	0.000167	0.0026	CbGeAlD
Ziprasidone—HTR1A—central nervous system—Alzheimer's disease	0.000166	0.00259	CbGeAlD
Ziprasidone—HTR7—nervous system—Alzheimer's disease	0.000165	0.00258	CbGeAlD
Ziprasidone—HTR1B—brain—Alzheimer's disease	0.000164	0.00255	CbGeAlD
Ziprasidone—CHRM2—brain—Alzheimer's disease	0.000163	0.00254	CbGeAlD
Ziprasidone—HTR1A—cerebellum—Alzheimer's disease	0.000162	0.00254	CbGeAlD
Ziprasidone—Aripiprazole—HTR2A—Alzheimer's disease	0.000161	0.0593	CrCbGaD
Ziprasidone—Trazodone—HTR2A—Alzheimer's disease	0.00016	0.059	CrCbGaD
Ziprasidone—ADRA1A—nervous system—Alzheimer's disease	0.000159	0.00248	CbGeAlD
Ziprasidone—HTR7—central nervous system—Alzheimer's disease	0.000159	0.00248	CbGeAlD
Ziprasidone—CYP2D6—telencephalon—Alzheimer's disease	0.000159	0.00248	CbGeAlD
Ziprasidone—HTR1D—brain—Alzheimer's disease	0.000158	0.00247	CbGeAlD
Ziprasidone—HTR2C—brain—Alzheimer's disease	0.000157	0.00245	CbGeAlD
Ziprasidone—DRD2—nervous system—Alzheimer's disease	0.000156	0.00243	CbGeAlD
Ziprasidone—HTR7—cerebellum—Alzheimer's disease	0.000155	0.00242	CbGeAlD
Ziprasidone—KCNH2—nervous system—Alzheimer's disease	0.000154	0.0024	CbGeAlD
Ziprasidone—ADRA1A—central nervous system—Alzheimer's disease	0.000153	0.00239	CbGeAlD
Ziprasidone—ADRA2C—nervous system—Alzheimer's disease	0.000152	0.00237	CbGeAlD
Ziprasidone—DRD2—central nervous system—Alzheimer's disease	0.00015	0.00234	CbGeAlD
Ziprasidone—ADRA1A—cerebellum—Alzheimer's disease	0.00015	0.00234	CbGeAlD
Ziprasidone—SLC6A4—brain—Alzheimer's disease	0.000149	0.00232	CbGeAlD
Ziprasidone—CHRM1—brain—Alzheimer's disease	0.000148	0.00231	CbGeAlD
Ziprasidone—KCNH2—central nervous system—Alzheimer's disease	0.000148	0.00231	CbGeAlD
Ziprasidone—Aripiprazole—CYP2D6—Alzheimer's disease	0.000147	0.0542	CrCbGaD
Ziprasidone—DRD2—cerebellum—Alzheimer's disease	0.000147	0.00229	CbGeAlD
Ziprasidone—Trazodone—CYP2D6—Alzheimer's disease	0.000147	0.054	CrCbGaD
Ziprasidone—ADRA2C—central nervous system—Alzheimer's disease	0.000146	0.00228	CbGeAlD
Ziprasidone—KCNH2—cerebellum—Alzheimer's disease	0.000145	0.00226	CbGeAlD
Ziprasidone—ADRA2C—cerebellum—Alzheimer's disease	0.000143	0.00223	CbGeAlD
Ziprasidone—Visual impairment—Donepezil—Alzheimer's disease	0.000135	0.000846	CcSEcCtD
Ziprasidone—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000135	0.000844	CcSEcCtD
Ziprasidone—Arthralgia—Galantamine—Alzheimer's disease	0.000134	0.000839	CcSEcCtD
Ziprasidone—Myalgia—Galantamine—Alzheimer's disease	0.000134	0.000839	CcSEcCtD
Ziprasidone—Chest pain—Galantamine—Alzheimer's disease	0.000134	0.000839	CcSEcCtD
Ziprasidone—Epistaxis—Memantine—Alzheimer's disease	0.000134	0.000837	CcSEcCtD
Ziprasidone—Anxiety—Galantamine—Alzheimer's disease	0.000134	0.000837	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000133	0.000834	CcSEcCtD
Ziprasidone—Sweating—Rivastigmine—Alzheimer's disease	0.000133	0.000833	CcSEcCtD
Ziprasidone—Haematuria—Rivastigmine—Alzheimer's disease	0.000133	0.000828	CcSEcCtD
Ziprasidone—CHRM3—brain—Alzheimer's disease	0.000133	0.00207	CbGeAlD
Ziprasidone—HTR1A—brain—Alzheimer's disease	0.000132	0.00206	CbGeAlD
Ziprasidone—Dry mouth—Galantamine—Alzheimer's disease	0.000131	0.000821	CcSEcCtD
Ziprasidone—Epistaxis—Rivastigmine—Alzheimer's disease	0.000131	0.000819	CcSEcCtD
Ziprasidone—Tinnitus—Donepezil—Alzheimer's disease	0.000131	0.000818	CcSEcCtD
Ziprasidone—Confusional state—Galantamine—Alzheimer's disease	0.00013	0.000811	CcSEcCtD
Ziprasidone—Bradycardia—Memantine—Alzheimer's disease	0.00013	0.000811	CcSEcCtD
Ziprasidone—Haemoglobin—Memantine—Alzheimer's disease	0.000128	0.000801	CcSEcCtD
Ziprasidone—Rhinitis—Memantine—Alzheimer's disease	0.000128	0.000799	CcSEcCtD
Ziprasidone—Hepatitis—Memantine—Alzheimer's disease	0.000128	0.000797	CcSEcCtD
Ziprasidone—Haemorrhage—Memantine—Alzheimer's disease	0.000128	0.000797	CcSEcCtD
Ziprasidone—Bradycardia—Rivastigmine—Alzheimer's disease	0.000127	0.000794	CcSEcCtD
Ziprasidone—Hypoaesthesia—Memantine—Alzheimer's disease	0.000127	0.000793	CcSEcCtD
Ziprasidone—Shock—Galantamine—Alzheimer's disease	0.000127	0.000792	CcSEcCtD
Ziprasidone—Pharyngitis—Memantine—Alzheimer's disease	0.000127	0.000791	CcSEcCtD
Ziprasidone—Nervous system disorder—Galantamine—Alzheimer's disease	0.000126	0.000789	CcSEcCtD
Ziprasidone—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000126	0.000788	CcSEcCtD
Ziprasidone—HTR7—brain—Alzheimer's disease	0.000126	0.00197	CbGeAlD
Ziprasidone—Chills—Donepezil—Alzheimer's disease	0.000126	0.000788	CcSEcCtD
Ziprasidone—Urinary tract disorder—Memantine—Alzheimer's disease	0.000126	0.000787	CcSEcCtD
Ziprasidone—Tachycardia—Galantamine—Alzheimer's disease	0.000126	0.000785	CcSEcCtD
Ziprasidone—Oedema peripheral—Memantine—Alzheimer's disease	0.000126	0.000785	CcSEcCtD
Ziprasidone—Arrhythmia—Donepezil—Alzheimer's disease	0.000126	0.000784	CcSEcCtD
Ziprasidone—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000125	0.000784	CcSEcCtD
Ziprasidone—Connective tissue disorder—Memantine—Alzheimer's disease	0.000125	0.000783	CcSEcCtD
Ziprasidone—Rhinitis—Rivastigmine—Alzheimer's disease	0.000125	0.000782	CcSEcCtD
Ziprasidone—Skin disorder—Galantamine—Alzheimer's disease	0.000125	0.000782	CcSEcCtD
Ziprasidone—Urethral disorder—Memantine—Alzheimer's disease	0.000125	0.000781	CcSEcCtD
Ziprasidone—Hepatitis—Rivastigmine—Alzheimer's disease	0.000125	0.00078	CcSEcCtD
Ziprasidone—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000125	0.00078	CcSEcCtD
Ziprasidone—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000125	0.000778	CcSEcCtD
Ziprasidone—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000124	0.000776	CcSEcCtD
Ziprasidone—Alopecia—Donepezil—Alzheimer's disease	0.000124	0.000776	CcSEcCtD
Ziprasidone—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000124	0.000774	CcSEcCtD
Ziprasidone—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000123	0.00077	CcSEcCtD
Ziprasidone—HRH1—nervous system—Alzheimer's disease	0.000123	0.00192	CbGeAlD
Ziprasidone—Mental disorder—Donepezil—Alzheimer's disease	0.000123	0.000769	CcSEcCtD
Ziprasidone—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000123	0.000768	CcSEcCtD
Ziprasidone—Visual impairment—Memantine—Alzheimer's disease	0.000123	0.000768	CcSEcCtD
Ziprasidone—Anorexia—Galantamine—Alzheimer's disease	0.000123	0.000767	CcSEcCtD
Ziprasidone—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000123	0.000766	CcSEcCtD
Ziprasidone—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000122	0.000764	CcSEcCtD
Ziprasidone—Malnutrition—Donepezil—Alzheimer's disease	0.000122	0.000764	CcSEcCtD
Ziprasidone—Erythema—Donepezil—Alzheimer's disease	0.000122	0.000764	CcSEcCtD
Ziprasidone—ADRA1A—brain—Alzheimer's disease	0.000122	0.0019	CbGeAlD
Ziprasidone—ADRA2A—nervous system—Alzheimer's disease	0.000121	0.00189	CbGeAlD
Ziprasidone—Flatulence—Donepezil—Alzheimer's disease	0.000121	0.000753	CcSEcCtD
Ziprasidone—Hypotension—Galantamine—Alzheimer's disease	0.00012	0.000752	CcSEcCtD
Ziprasidone—Visual impairment—Rivastigmine—Alzheimer's disease	0.00012	0.000751	CcSEcCtD
Ziprasidone—DRD2—brain—Alzheimer's disease	0.000119	0.00186	CbGeAlD
Ziprasidone—Eye disorder—Memantine—Alzheimer's disease	0.000119	0.000745	CcSEcCtD
Ziprasidone—Tinnitus—Memantine—Alzheimer's disease	0.000119	0.000743	CcSEcCtD
Ziprasidone—HRH1—central nervous system—Alzheimer's disease	0.000119	0.00185	CbGeAlD
Ziprasidone—Cardiac disorder—Memantine—Alzheimer's disease	0.000118	0.00074	CcSEcCtD
Ziprasidone—Back pain—Donepezil—Alzheimer's disease	0.000118	0.000739	CcSEcCtD
Ziprasidone—Muscle spasms—Donepezil—Alzheimer's disease	0.000118	0.000735	CcSEcCtD
Ziprasidone—KCNH2—brain—Alzheimer's disease	0.000118	0.00183	CbGeAlD
Ziprasidone—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000117	0.000733	CcSEcCtD
Ziprasidone—Eye disorder—Rivastigmine—Alzheimer's disease	0.000117	0.000729	CcSEcCtD
Ziprasidone—ADRA2A—central nervous system—Alzheimer's disease	0.000117	0.00182	CbGeAlD
Ziprasidone—Insomnia—Galantamine—Alzheimer's disease	0.000117	0.000728	CcSEcCtD
Ziprasidone—Tinnitus—Rivastigmine—Alzheimer's disease	0.000116	0.000727	CcSEcCtD
Ziprasidone—ADRA2C—brain—Alzheimer's disease	0.000116	0.00181	CbGeAlD
Ziprasidone—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000116	0.000724	CcSEcCtD
Ziprasidone—Angiopathy—Memantine—Alzheimer's disease	0.000116	0.000723	CcSEcCtD
Ziprasidone—Paraesthesia—Galantamine—Alzheimer's disease	0.000116	0.000723	CcSEcCtD
Ziprasidone—Vision blurred—Donepezil—Alzheimer's disease	0.000115	0.00072	CcSEcCtD
Ziprasidone—Immune system disorder—Memantine—Alzheimer's disease	0.000115	0.00072	CcSEcCtD
Ziprasidone—Mediastinal disorder—Memantine—Alzheimer's disease	0.000115	0.000718	CcSEcCtD
Ziprasidone—Tremor—Donepezil—Alzheimer's disease	0.000115	0.000716	CcSEcCtD
Ziprasidone—Somnolence—Galantamine—Alzheimer's disease	0.000115	0.000715	CcSEcCtD
Ziprasidone—Chills—Memantine—Alzheimer's disease	0.000114	0.000715	CcSEcCtD
Ziprasidone—Arrhythmia—Memantine—Alzheimer's disease	0.000114	0.000712	CcSEcCtD
Ziprasidone—ADRA2A—cerebellum—Alzheimer's disease	0.000114	0.00178	CbGeAlD
Ziprasidone—Dyspepsia—Galantamine—Alzheimer's disease	0.000113	0.000708	CcSEcCtD
Ziprasidone—Angiopathy—Rivastigmine—Alzheimer's disease	0.000113	0.000707	CcSEcCtD
Ziprasidone—Anaemia—Donepezil—Alzheimer's disease	0.000113	0.000706	CcSEcCtD
Ziprasidone—Alopecia—Memantine—Alzheimer's disease	0.000113	0.000704	CcSEcCtD
Ziprasidone—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000113	0.000703	CcSEcCtD
Ziprasidone—Agitation—Donepezil—Alzheimer's disease	0.000112	0.000702	CcSEcCtD
Ziprasidone—Chills—Rivastigmine—Alzheimer's disease	0.000112	0.0007	CcSEcCtD
Ziprasidone—Decreased appetite—Galantamine—Alzheimer's disease	0.000112	0.0007	CcSEcCtD
Ziprasidone—Mental disorder—Memantine—Alzheimer's disease	0.000112	0.000698	CcSEcCtD
Ziprasidone—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000112	0.000697	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000111	0.000695	CcSEcCtD
Ziprasidone—Malnutrition—Memantine—Alzheimer's disease	0.000111	0.000694	CcSEcCtD
Ziprasidone—Fatigue—Galantamine—Alzheimer's disease	0.000111	0.000694	CcSEcCtD
Ziprasidone—Alopecia—Rivastigmine—Alzheimer's disease	0.00011	0.000689	CcSEcCtD
Ziprasidone—Constipation—Galantamine—Alzheimer's disease	0.00011	0.000688	CcSEcCtD
Ziprasidone—Vertigo—Donepezil—Alzheimer's disease	0.00011	0.000687	CcSEcCtD
Ziprasidone—Syncope—Donepezil—Alzheimer's disease	0.00011	0.000685	CcSEcCtD
Ziprasidone—Flatulence—Memantine—Alzheimer's disease	0.000109	0.000684	CcSEcCtD
Ziprasidone—Mental disorder—Rivastigmine—Alzheimer's disease	0.000109	0.000683	CcSEcCtD
Ziprasidone—Erythema—Rivastigmine—Alzheimer's disease	0.000109	0.000679	CcSEcCtD
Ziprasidone—Malnutrition—Rivastigmine—Alzheimer's disease	0.000109	0.000679	CcSEcCtD
Ziprasidone—Loss of consciousness—Donepezil—Alzheimer's disease	0.000108	0.000672	CcSEcCtD
Ziprasidone—Back pain—Memantine—Alzheimer's disease	0.000107	0.000671	CcSEcCtD
Ziprasidone—Flatulence—Rivastigmine—Alzheimer's disease	0.000107	0.000669	CcSEcCtD
Ziprasidone—Cough—Donepezil—Alzheimer's disease	0.000107	0.000667	CcSEcCtD
Ziprasidone—Feeling abnormal—Galantamine—Alzheimer's disease	0.000106	0.000663	CcSEcCtD
Ziprasidone—Hypertension—Donepezil—Alzheimer's disease	0.000106	0.00066	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000105	0.000658	CcSEcCtD
Ziprasidone—Back pain—Rivastigmine—Alzheimer's disease	0.000105	0.000657	CcSEcCtD
Ziprasidone—Vision blurred—Memantine—Alzheimer's disease	0.000105	0.000654	CcSEcCtD
Ziprasidone—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000104	0.000653	CcSEcCtD
Ziprasidone—Myalgia—Donepezil—Alzheimer's disease	0.000104	0.000651	CcSEcCtD
Ziprasidone—Chest pain—Donepezil—Alzheimer's disease	0.000104	0.000651	CcSEcCtD
Ziprasidone—Arthralgia—Donepezil—Alzheimer's disease	0.000104	0.000651	CcSEcCtD
Ziprasidone—Tremor—Memantine—Alzheimer's disease	0.000104	0.00065	CcSEcCtD
Ziprasidone—Anxiety—Donepezil—Alzheimer's disease	0.000104	0.000648	CcSEcCtD
Ziprasidone—HTR2A—nervous system—Alzheimer's disease	0.000103	0.00161	CbGeAlD
Ziprasidone—Anaemia—Memantine—Alzheimer's disease	0.000103	0.000641	CcSEcCtD
Ziprasidone—Vision blurred—Rivastigmine—Alzheimer's disease	0.000102	0.00064	CcSEcCtD
Ziprasidone—Agitation—Memantine—Alzheimer's disease	0.000102	0.000638	CcSEcCtD
Ziprasidone—Dry mouth—Donepezil—Alzheimer's disease	0.000102	0.000636	CcSEcCtD
Ziprasidone—Body temperature increased—Galantamine—Alzheimer's disease	0.000102	0.000636	CcSEcCtD
Ziprasidone—Abdominal pain—Galantamine—Alzheimer's disease	0.000102	0.000636	CcSEcCtD
Ziprasidone—Tremor—Rivastigmine—Alzheimer's disease	0.000102	0.000636	CcSEcCtD
Ziprasidone—Confusional state—Donepezil—Alzheimer's disease	0.000101	0.000629	CcSEcCtD
Ziprasidone—Anaemia—Rivastigmine—Alzheimer's disease	0.0001	0.000627	CcSEcCtD
Ziprasidone—Agitation—Rivastigmine—Alzheimer's disease	9.99e-05	0.000624	CcSEcCtD
Ziprasidone—Vertigo—Memantine—Alzheimer's disease	9.98e-05	0.000623	CcSEcCtD
Ziprasidone—Syncope—Memantine—Alzheimer's disease	9.96e-05	0.000622	CcSEcCtD
Ziprasidone—Leukopenia—Memantine—Alzheimer's disease	9.94e-05	0.000621	CcSEcCtD
Ziprasidone—Infection—Donepezil—Alzheimer's disease	9.92e-05	0.00062	CcSEcCtD
Ziprasidone—HTR2A—central nervous system—Alzheimer's disease	9.91e-05	0.00155	CbGeAlD
Ziprasidone—Shock—Donepezil—Alzheimer's disease	9.82e-05	0.000614	CcSEcCtD
Ziprasidone—Palpitations—Memantine—Alzheimer's disease	9.82e-05	0.000613	CcSEcCtD
Ziprasidone—Nervous system disorder—Donepezil—Alzheimer's disease	9.79e-05	0.000612	CcSEcCtD
Ziprasidone—Thrombocytopenia—Donepezil—Alzheimer's disease	9.78e-05	0.000611	CcSEcCtD
Ziprasidone—Vertigo—Rivastigmine—Alzheimer's disease	9.76e-05	0.00061	CcSEcCtD
Ziprasidone—Loss of consciousness—Memantine—Alzheimer's disease	9.76e-05	0.00061	CcSEcCtD
Ziprasidone—Syncope—Rivastigmine—Alzheimer's disease	9.74e-05	0.000609	CcSEcCtD
Ziprasidone—Cough—Memantine—Alzheimer's disease	9.69e-05	0.000605	CcSEcCtD
Ziprasidone—HTR2A—cerebellum—Alzheimer's disease	9.68e-05	0.00151	CbGeAlD
Ziprasidone—Hyperhidrosis—Donepezil—Alzheimer's disease	9.65e-05	0.000603	CcSEcCtD
Ziprasidone—Palpitations—Rivastigmine—Alzheimer's disease	9.6e-05	0.0006	CcSEcCtD
Ziprasidone—Hypertension—Memantine—Alzheimer's disease	9.59e-05	0.000599	CcSEcCtD
Ziprasidone—Loss of consciousness—Rivastigmine—Alzheimer's disease	9.55e-05	0.000597	CcSEcCtD
Ziprasidone—CYP3A4—nervous system—Alzheimer's disease	9.53e-05	0.00149	CbGeAlD
Ziprasidone—Anorexia—Donepezil—Alzheimer's disease	9.52e-05	0.000594	CcSEcCtD
Ziprasidone—Hypersensitivity—Galantamine—Alzheimer's disease	9.49e-05	0.000593	CcSEcCtD
Ziprasidone—Cough—Rivastigmine—Alzheimer's disease	9.48e-05	0.000592	CcSEcCtD
Ziprasidone—Arthralgia—Memantine—Alzheimer's disease	9.46e-05	0.000591	CcSEcCtD
Ziprasidone—Chest pain—Memantine—Alzheimer's disease	9.46e-05	0.000591	CcSEcCtD
Ziprasidone—Myalgia—Memantine—Alzheimer's disease	9.46e-05	0.000591	CcSEcCtD
Ziprasidone—Anxiety—Memantine—Alzheimer's disease	9.42e-05	0.000589	CcSEcCtD
Ziprasidone—HRH1—brain—Alzheimer's disease	9.42e-05	0.00147	CbGeAlD
Ziprasidone—Hypertension—Rivastigmine—Alzheimer's disease	9.38e-05	0.000586	CcSEcCtD
Ziprasidone—CYP2D6—nervous system—Alzheimer's disease	9.37e-05	0.00146	CbGeAlD
Ziprasidone—Hypotension—Donepezil—Alzheimer's disease	9.33e-05	0.000583	CcSEcCtD
Ziprasidone—Chest pain—Rivastigmine—Alzheimer's disease	9.25e-05	0.000578	CcSEcCtD
Ziprasidone—Arthralgia—Rivastigmine—Alzheimer's disease	9.25e-05	0.000578	CcSEcCtD
Ziprasidone—Myalgia—Rivastigmine—Alzheimer's disease	9.25e-05	0.000578	CcSEcCtD
Ziprasidone—ADRA2A—brain—Alzheimer's disease	9.25e-05	0.00144	CbGeAlD
Ziprasidone—Dry mouth—Memantine—Alzheimer's disease	9.25e-05	0.000578	CcSEcCtD
Ziprasidone—Asthenia—Galantamine—Alzheimer's disease	9.24e-05	0.000577	CcSEcCtD
Ziprasidone—Anxiety—Rivastigmine—Alzheimer's disease	9.22e-05	0.000576	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	9.19e-05	0.000574	CcSEcCtD
Ziprasidone—CYP3A4—central nervous system—Alzheimer's disease	9.17e-05	0.00143	CbGeAlD
Ziprasidone—Confusional state—Memantine—Alzheimer's disease	9.14e-05	0.000571	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	9.1e-05	0.000568	CcSEcCtD
Ziprasidone—Dry mouth—Rivastigmine—Alzheimer's disease	9.05e-05	0.000565	CcSEcCtD
Ziprasidone—Insomnia—Donepezil—Alzheimer's disease	9.03e-05	0.000564	CcSEcCtD
Ziprasidone—CYP2D6—central nervous system—Alzheimer's disease	9.03e-05	0.00141	CbGeAlD
Ziprasidone—Infection—Memantine—Alzheimer's disease	9.01e-05	0.000563	CcSEcCtD
Ziprasidone—Paraesthesia—Donepezil—Alzheimer's disease	8.97e-05	0.00056	CcSEcCtD
Ziprasidone—Confusional state—Rivastigmine—Alzheimer's disease	8.94e-05	0.000559	CcSEcCtD
Ziprasidone—Shock—Memantine—Alzheimer's disease	8.92e-05	0.000557	CcSEcCtD
Ziprasidone—Dyspnoea—Donepezil—Alzheimer's disease	8.9e-05	0.000556	CcSEcCtD
Ziprasidone—Nervous system disorder—Memantine—Alzheimer's disease	8.89e-05	0.000555	CcSEcCtD
Ziprasidone—Somnolence—Donepezil—Alzheimer's disease	8.88e-05	0.000554	CcSEcCtD
Ziprasidone—Thrombocytopenia—Memantine—Alzheimer's disease	8.88e-05	0.000554	CcSEcCtD
Ziprasidone—Tachycardia—Memantine—Alzheimer's disease	8.85e-05	0.000553	CcSEcCtD
Ziprasidone—CYP2D6—cerebellum—Alzheimer's disease	8.82e-05	0.00138	CbGeAlD
Ziprasidone—Diarrhoea—Galantamine—Alzheimer's disease	8.81e-05	0.000551	CcSEcCtD
Ziprasidone—Infection—Rivastigmine—Alzheimer's disease	8.81e-05	0.00055	CcSEcCtD
Ziprasidone—Skin disorder—Memantine—Alzheimer's disease	8.81e-05	0.00055	CcSEcCtD
Ziprasidone—Dyspepsia—Donepezil—Alzheimer's disease	8.79e-05	0.000549	CcSEcCtD
Ziprasidone—Hyperhidrosis—Memantine—Alzheimer's disease	8.76e-05	0.000547	CcSEcCtD
Ziprasidone—Shock—Rivastigmine—Alzheimer's disease	8.73e-05	0.000545	CcSEcCtD
Ziprasidone—Nervous system disorder—Rivastigmine—Alzheimer's disease	8.7e-05	0.000543	CcSEcCtD
Ziprasidone—Thrombocytopenia—Rivastigmine—Alzheimer's disease	8.68e-05	0.000542	CcSEcCtD
Ziprasidone—Decreased appetite—Donepezil—Alzheimer's disease	8.68e-05	0.000542	CcSEcCtD
Ziprasidone—Clozapine—HTR2A—Alzheimer's disease	8.66e-05	0.0319	CrCbGaD
Ziprasidone—Tachycardia—Rivastigmine—Alzheimer's disease	8.66e-05	0.000541	CcSEcCtD
Ziprasidone—Anorexia—Memantine—Alzheimer's disease	8.64e-05	0.00054	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Donepezil—Alzheimer's disease	8.62e-05	0.000538	CcSEcCtD
Ziprasidone—Skin disorder—Rivastigmine—Alzheimer's disease	8.61e-05	0.000538	CcSEcCtD
Ziprasidone—Fatigue—Donepezil—Alzheimer's disease	8.61e-05	0.000538	CcSEcCtD
Ziprasidone—Hyperhidrosis—Rivastigmine—Alzheimer's disease	8.57e-05	0.000536	CcSEcCtD
Ziprasidone—Constipation—Donepezil—Alzheimer's disease	8.54e-05	0.000533	CcSEcCtD
Ziprasidone—Dizziness—Galantamine—Alzheimer's disease	8.52e-05	0.000532	CcSEcCtD
Ziprasidone—Hypotension—Memantine—Alzheimer's disease	8.47e-05	0.000529	CcSEcCtD
Ziprasidone—Anorexia—Rivastigmine—Alzheimer's disease	8.45e-05	0.000528	CcSEcCtD
Ziprasidone—Hypotension—Rivastigmine—Alzheimer's disease	8.29e-05	0.000518	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Memantine—Alzheimer's disease	8.26e-05	0.000516	CcSEcCtD
Ziprasidone—Feeling abnormal—Donepezil—Alzheimer's disease	8.23e-05	0.000514	CcSEcCtD
Ziprasidone—Insomnia—Memantine—Alzheimer's disease	8.2e-05	0.000512	CcSEcCtD
Ziprasidone—Vomiting—Galantamine—Alzheimer's disease	8.19e-05	0.000512	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Donepezil—Alzheimer's disease	8.16e-05	0.00051	CcSEcCtD
Ziprasidone—Paraesthesia—Memantine—Alzheimer's disease	8.14e-05	0.000508	CcSEcCtD
Ziprasidone—Rash—Galantamine—Alzheimer's disease	8.12e-05	0.000507	CcSEcCtD
Ziprasidone—Dermatitis—Galantamine—Alzheimer's disease	8.12e-05	0.000507	CcSEcCtD
Ziprasidone—Dyspnoea—Memantine—Alzheimer's disease	8.08e-05	0.000505	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	8.08e-05	0.000505	CcSEcCtD
Ziprasidone—Headache—Galantamine—Alzheimer's disease	8.07e-05	0.000504	CcSEcCtD
Ziprasidone—Somnolence—Memantine—Alzheimer's disease	8.06e-05	0.000503	CcSEcCtD
Ziprasidone—Insomnia—Rivastigmine—Alzheimer's disease	8.02e-05	0.000501	CcSEcCtD
Ziprasidone—Dyspepsia—Memantine—Alzheimer's disease	7.98e-05	0.000498	CcSEcCtD
Ziprasidone—Paraesthesia—Rivastigmine—Alzheimer's disease	7.96e-05	0.000497	CcSEcCtD
Ziprasidone—Urticaria—Donepezil—Alzheimer's disease	7.93e-05	0.000495	CcSEcCtD
Ziprasidone—Clozapine—CYP2D6—Alzheimer's disease	7.92e-05	0.0292	CrCbGaD
Ziprasidone—Dyspnoea—Rivastigmine—Alzheimer's disease	7.91e-05	0.000494	CcSEcCtD
Ziprasidone—Abdominal pain—Donepezil—Alzheimer's disease	7.89e-05	0.000493	CcSEcCtD
Ziprasidone—Body temperature increased—Donepezil—Alzheimer's disease	7.89e-05	0.000493	CcSEcCtD
Ziprasidone—Somnolence—Rivastigmine—Alzheimer's disease	7.88e-05	0.000492	CcSEcCtD
Ziprasidone—Decreased appetite—Memantine—Alzheimer's disease	7.88e-05	0.000492	CcSEcCtD
Ziprasidone—HTR2A—brain—Alzheimer's disease	7.87e-05	0.00123	CbGeAlD
Ziprasidone—Gastrointestinal disorder—Memantine—Alzheimer's disease	7.83e-05	0.000489	CcSEcCtD
Ziprasidone—Fatigue—Memantine—Alzheimer's disease	7.82e-05	0.000488	CcSEcCtD
Ziprasidone—Dyspepsia—Rivastigmine—Alzheimer's disease	7.81e-05	0.000488	CcSEcCtD
Ziprasidone—Constipation—Memantine—Alzheimer's disease	7.75e-05	0.000484	CcSEcCtD
Ziprasidone—Decreased appetite—Rivastigmine—Alzheimer's disease	7.71e-05	0.000482	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	7.66e-05	0.000478	CcSEcCtD
Ziprasidone—Nausea—Galantamine—Alzheimer's disease	7.65e-05	0.000478	CcSEcCtD
Ziprasidone—Fatigue—Rivastigmine—Alzheimer's disease	7.65e-05	0.000478	CcSEcCtD
Ziprasidone—Constipation—Rivastigmine—Alzheimer's disease	7.58e-05	0.000474	CcSEcCtD
Ziprasidone—Feeling abnormal—Memantine—Alzheimer's disease	7.47e-05	0.000467	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Memantine—Alzheimer's disease	7.41e-05	0.000463	CcSEcCtD
Ziprasidone—Hypersensitivity—Donepezil—Alzheimer's disease	7.36e-05	0.000459	CcSEcCtD
Ziprasidone—Feeling abnormal—Rivastigmine—Alzheimer's disease	7.31e-05	0.000456	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	7.25e-05	0.000453	CcSEcCtD
Ziprasidone—Urticaria—Memantine—Alzheimer's disease	7.2e-05	0.00045	CcSEcCtD
Ziprasidone—Abdominal pain—Memantine—Alzheimer's disease	7.17e-05	0.000448	CcSEcCtD
Ziprasidone—Body temperature increased—Memantine—Alzheimer's disease	7.17e-05	0.000448	CcSEcCtD
Ziprasidone—CYP2D6—brain—Alzheimer's disease	7.17e-05	0.00112	CbGeAlD
Ziprasidone—Asthenia—Donepezil—Alzheimer's disease	7.16e-05	0.000447	CcSEcCtD
Ziprasidone—Urticaria—Rivastigmine—Alzheimer's disease	7.05e-05	0.00044	CcSEcCtD
Ziprasidone—Body temperature increased—Rivastigmine—Alzheimer's disease	7.01e-05	0.000438	CcSEcCtD
Ziprasidone—Abdominal pain—Rivastigmine—Alzheimer's disease	7.01e-05	0.000438	CcSEcCtD
Ziprasidone—Diarrhoea—Donepezil—Alzheimer's disease	6.83e-05	0.000427	CcSEcCtD
Ziprasidone—Hypersensitivity—Memantine—Alzheimer's disease	6.68e-05	0.000417	CcSEcCtD
Ziprasidone—Dizziness—Donepezil—Alzheimer's disease	6.6e-05	0.000412	CcSEcCtD
Ziprasidone—Hypersensitivity—Rivastigmine—Alzheimer's disease	6.53e-05	0.000408	CcSEcCtD
Ziprasidone—Asthenia—Memantine—Alzheimer's disease	6.5e-05	0.000406	CcSEcCtD
Ziprasidone—Asthenia—Rivastigmine—Alzheimer's disease	6.36e-05	0.000397	CcSEcCtD
Ziprasidone—Vomiting—Donepezil—Alzheimer's disease	6.35e-05	0.000397	CcSEcCtD
Ziprasidone—Rash—Donepezil—Alzheimer's disease	6.3e-05	0.000393	CcSEcCtD
Ziprasidone—Dermatitis—Donepezil—Alzheimer's disease	6.29e-05	0.000393	CcSEcCtD
Ziprasidone—Headache—Donepezil—Alzheimer's disease	6.25e-05	0.000391	CcSEcCtD
Ziprasidone—Diarrhoea—Memantine—Alzheimer's disease	6.2e-05	0.000387	CcSEcCtD
Ziprasidone—Diarrhoea—Rivastigmine—Alzheimer's disease	6.07e-05	0.000379	CcSEcCtD
Ziprasidone—Dizziness—Memantine—Alzheimer's disease	5.99e-05	0.000374	CcSEcCtD
Ziprasidone—Nausea—Donepezil—Alzheimer's disease	5.93e-05	0.00037	CcSEcCtD
Ziprasidone—Dizziness—Rivastigmine—Alzheimer's disease	5.86e-05	0.000366	CcSEcCtD
Ziprasidone—Vomiting—Memantine—Alzheimer's disease	5.76e-05	0.00036	CcSEcCtD
Ziprasidone—Rash—Memantine—Alzheimer's disease	5.72e-05	0.000357	CcSEcCtD
Ziprasidone—Dermatitis—Memantine—Alzheimer's disease	5.71e-05	0.000357	CcSEcCtD
Ziprasidone—Headache—Memantine—Alzheimer's disease	5.68e-05	0.000355	CcSEcCtD
Ziprasidone—Vomiting—Rivastigmine—Alzheimer's disease	5.64e-05	0.000352	CcSEcCtD
Ziprasidone—Rash—Rivastigmine—Alzheimer's disease	5.59e-05	0.000349	CcSEcCtD
Ziprasidone—Dermatitis—Rivastigmine—Alzheimer's disease	5.59e-05	0.000349	CcSEcCtD
Ziprasidone—Headache—Rivastigmine—Alzheimer's disease	5.56e-05	0.000347	CcSEcCtD
Ziprasidone—Nausea—Memantine—Alzheimer's disease	5.38e-05	0.000336	CcSEcCtD
Ziprasidone—Nausea—Rivastigmine—Alzheimer's disease	5.27e-05	0.000329	CcSEcCtD
Ziprasidone—DRD5—Signaling Pathways—TP53—Alzheimer's disease	1.78e-06	2.3e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	1.78e-06	2.3e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—MAPK8—Alzheimer's disease	1.78e-06	2.3e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	1.78e-06	2.29e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	1.78e-06	2.29e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—AKT1—Alzheimer's disease	1.78e-06	2.29e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	1.78e-06	2.29e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	1.77e-06	2.28e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.77e-06	2.28e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	1.77e-06	2.28e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—NOS3—Alzheimer's disease	1.76e-06	2.27e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.75e-06	2.26e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—PTGS2—Alzheimer's disease	1.75e-06	2.26e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	1.75e-06	2.26e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	1.75e-06	2.25e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—VEGFA—Alzheimer's disease	1.74e-06	2.24e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—VEGFA—Alzheimer's disease	1.72e-06	2.21e-05	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—AKT1—Alzheimer's disease	1.7e-06	2.19e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	1.7e-06	2.19e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	1.7e-06	2.19e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	1.7e-06	2.19e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	1.69e-06	2.18e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	1.69e-06	2.18e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	1.69e-06	2.17e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	1.68e-06	2.16e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—MAPK8—Alzheimer's disease	1.67e-06	2.16e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—TGFB1—Alzheimer's disease	1.67e-06	2.15e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—AKT1—Alzheimer's disease	1.67e-06	2.15e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—TGFB1—Alzheimer's disease	1.67e-06	2.15e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.66e-06	2.14e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	1.66e-06	2.14e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—TGFB1—Alzheimer's disease	1.66e-06	2.14e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	1.65e-06	2.13e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	1.65e-06	2.12e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—VEGFA—Alzheimer's disease	1.64e-06	2.12e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	1.64e-06	2.12e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	1.64e-06	2.12e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	1.63e-06	2.11e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—IL6—Alzheimer's disease	1.63e-06	2.1e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.62e-06	2.09e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	1.62e-06	2.09e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	1.62e-06	2.08e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	1.61e-06	2.08e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—NOS3—Alzheimer's disease	1.61e-06	2.08e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	1.61e-06	2.07e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	1.61e-06	2.07e-05	CbGpPWpGaD
Ziprasidone—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.6e-06	2.07e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	1.6e-06	2.06e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—TGFB1—Alzheimer's disease	1.6e-06	2.06e-05	CbGpPWpGaD
Ziprasidone—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.59e-06	2.05e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	1.59e-06	2.05e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	1.59e-06	2.04e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	1.58e-06	2.04e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	1.58e-06	2.04e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	1.58e-06	2.03e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—TGFB1—Alzheimer's disease	1.58e-06	2.03e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	1.57e-06	2.02e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.57e-06	2.02e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	1.57e-06	2.02e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.55e-06	2e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—VEGFA—Alzheimer's disease	1.55e-06	1.99e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.55e-06	1.99e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	1.54e-06	1.98e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.53e-06	1.98e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.53e-06	1.97e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	1.53e-06	1.97e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	1.53e-06	1.97e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.52e-06	1.96e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.52e-06	1.95e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	1.51e-06	1.95e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	1.51e-06	1.95e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—TGFB1—Alzheimer's disease	1.51e-06	1.95e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	1.51e-06	1.94e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—AKT1—Alzheimer's disease	1.5e-06	1.94e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	1.5e-06	1.94e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	1.47e-06	1.9e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	1.47e-06	1.89e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.46e-06	1.88e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.46e-06	1.88e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.45e-06	1.87e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.45e-06	1.87e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	1.44e-06	1.85e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TGFB1—Alzheimer's disease	1.42e-06	1.83e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.41e-06	1.82e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.41e-06	1.82e-05	CbGpPWpGaD
Ziprasidone—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.41e-06	1.81e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	1.4e-06	1.8e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	1.39e-06	1.8e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.39e-06	1.79e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	1.39e-06	1.79e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	1.39e-06	1.79e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	1.39e-06	1.79e-05	CbGpPWpGaD
Ziprasidone—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.38e-06	1.78e-05	CbGpPWpGaD
Ziprasidone—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.38e-06	1.78e-05	CbGpPWpGaD
Ziprasidone—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.38e-06	1.77e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—TP53—Alzheimer's disease	1.38e-06	1.77e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—TP53—Alzheimer's disease	1.37e-06	1.77e-05	CbGpPWpGaD
Ziprasidone—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	1.37e-06	1.77e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	1.37e-06	1.77e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	1.37e-06	1.76e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—TP53—Alzheimer's disease	1.37e-06	1.76e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	1.36e-06	1.76e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	1.36e-06	1.76e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	1.36e-06	1.75e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	1.36e-06	1.75e-05	CbGpPWpGaD
Ziprasidone—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.36e-06	1.75e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.36e-06	1.75e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	1.36e-06	1.75e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	1.35e-06	1.74e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.35e-06	1.74e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	1.35e-06	1.74e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	1.34e-06	1.73e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.34e-06	1.73e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	1.34e-06	1.72e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—TP53—Alzheimer's disease	1.34e-06	1.72e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	1.33e-06	1.72e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.33e-06	1.72e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—TP53—Alzheimer's disease	1.32e-06	1.7e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.31e-06	1.69e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—INS—Alzheimer's disease	1.31e-06	1.68e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.3e-06	1.68e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.3e-06	1.68e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.3e-06	1.68e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—TP53—Alzheimer's disease	1.3e-06	1.67e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.3e-06	1.67e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.28e-06	1.65e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.28e-06	1.65e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.28e-06	1.65e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.28e-06	1.65e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.28e-06	1.65e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.26e-06	1.62e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.26e-06	1.62e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—IL6—Alzheimer's disease	1.26e-06	1.62e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	1.26e-06	1.62e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—IL6—Alzheimer's disease	1.26e-06	1.62e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.26e-06	1.62e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	1.25e-06	1.62e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.25e-06	1.62e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.25e-06	1.61e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	1.25e-06	1.61e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—IL6—Alzheimer's disease	1.25e-06	1.61e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	1.25e-06	1.61e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	1.25e-06	1.61e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—TP53—Alzheimer's disease	1.24e-06	1.6e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	1.24e-06	1.6e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	1.24e-06	1.6e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.24e-06	1.59e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	1.23e-06	1.59e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.23e-06	1.59e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.23e-06	1.59e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.23e-06	1.59e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—IL6—Alzheimer's disease	1.22e-06	1.58e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—IL6—Alzheimer's disease	1.2e-06	1.55e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.2e-06	1.54e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.19e-06	1.54e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—IL6—Alzheimer's disease	1.19e-06	1.53e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—TP53—Alzheimer's disease	1.18e-06	1.53e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.18e-06	1.52e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.18e-06	1.52e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TP53—Alzheimer's disease	1.17e-06	1.51e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.16e-06	1.5e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	1.16e-06	1.5e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—AKT1—Alzheimer's disease	1.16e-06	1.5e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—AKT1—Alzheimer's disease	1.16e-06	1.5e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.16e-06	1.49e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	1.15e-06	1.49e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—AKT1—Alzheimer's disease	1.15e-06	1.49e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.15e-06	1.48e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.15e-06	1.48e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.14e-06	1.47e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	1.14e-06	1.47e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.14e-06	1.47e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—IL6—Alzheimer's disease	1.14e-06	1.47e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—AKT1—Alzheimer's disease	1.13e-06	1.45e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.13e-06	1.45e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—AKT1—Alzheimer's disease	1.11e-06	1.43e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—INS—Alzheimer's disease	1.11e-06	1.43e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—AKT1—Alzheimer's disease	1.1e-06	1.41e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.09e-06	1.4e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—IL6—Alzheimer's disease	1.08e-06	1.4e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.07e-06	1.38e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—IL6—Alzheimer's disease	1.07e-06	1.38e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.07e-06	1.38e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	1.07e-06	1.37e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.06e-06	1.37e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	1.06e-06	1.37e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.06e-06	1.36e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	1.05e-06	1.36e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—AKT1—Alzheimer's disease	1.05e-06	1.35e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	1.05e-06	1.35e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.05e-06	1.35e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.05e-06	1.35e-05	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—AKT1—Alzheimer's disease	1.02e-06	1.32e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.02e-06	1.31e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	1.01e-06	1.31e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1e-06	1.29e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	1e-06	1.29e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—APOE—Alzheimer's disease	1e-06	1.29e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—AKT1—Alzheimer's disease	9.95e-07	1.28e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CAV1—Alzheimer's disease	9.91e-07	1.28e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—AKT1—Alzheimer's disease	9.87e-07	1.27e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	9.85e-07	1.27e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	9.72e-07	1.25e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—NOS3—Alzheimer's disease	9.71e-07	1.25e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	9.7e-07	1.25e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	9.66e-07	1.24e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	9.32e-07	1.2e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	9.27e-07	1.19e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	9.02e-07	1.16e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TP53—Alzheimer's disease	8.94e-07	1.15e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	8.91e-07	1.15e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	8.88e-07	1.14e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	8.88e-07	1.14e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—AKT1—Alzheimer's disease	8.81e-07	1.14e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	8.8e-07	1.13e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TP53—Alzheimer's disease	8.78e-07	1.13e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	8.75e-07	1.13e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	8.72e-07	1.12e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PPARG—Alzheimer's disease	8.71e-07	1.12e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	8.64e-07	1.11e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	8.61e-07	1.11e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	8.6e-07	1.11e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	8.55e-07	1.1e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—INS—Alzheimer's disease	8.54e-07	1.1e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	8.32e-07	1.07e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	8.19e-07	1.06e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IL6—Alzheimer's disease	8.18e-07	1.05e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—AKT1—Alzheimer's disease	8.08e-07	1.04e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	8.05e-07	1.04e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IL6—Alzheimer's disease	8.03e-07	1.04e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	8.01e-07	1.03e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	8e-07	1.03e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	7.98e-07	1.03e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	7.91e-07	1.02e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	7.88e-07	1.02e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	7.55e-07	9.73e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—NOS3—Alzheimer's disease	7.49e-07	9.65e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	7.43e-07	9.57e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	7.41e-07	9.55e-06	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—AKT1—Alzheimer's disease	7.41e-07	9.54e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	7.39e-07	9.52e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	7.37e-07	9.49e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	7.33e-07	9.44e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	7.29e-07	9.4e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	7.27e-07	9.37e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	6.85e-07	8.83e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	6.76e-07	8.71e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—AKT1—Alzheimer's disease	5.27e-07	6.79e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—AKT1—Alzheimer's disease	4.46e-07	5.75e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.44e-07	4.44e-06	CbGpPWpGaD
